ProCE Banner Activity

Choosing Between Initial ART Options: Answering the Questions

Podcast Episodes

Drs Marta Boffito and Michelle Cespedes discuss questions about first-line antiretroviral therapy, from Clinical Care Options (CCO)

Released: June 06, 2023

Share

Faculty

Marta Boffito

Marta Boffito, MD, PhD, FRCP, MBA

Consultant Physician
Clinical Director
HIV, Sexual and Gender Health, Dermatology
Chelsea and Westminster Hospital NHS Foundation Trust
Imperial College London
London, United Kingdom

Michelle Cespedes

Michelle Cespedes, MD, MS

Professor of Medicine
Division of Infectious Disease
Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Target Audience

This program is intended for physicians, registered nurses, pharmacists, nurse practitioners and physician associates/physician assistants, and other healthcare providers who care for persons with or at risk of HIV infection.

Program Learning Goal

The goal of this activity is to deliver the interprofessional HIV management team sustained education that will improve their knowledge and competence in making care decisions that address the needs of their individual patients.

Disclosure

Primary Author

Marta Boffito, MD, PhD, FRCP, MBA

Consultant Physician
Clinical Director
HIV, Sexual and Gender Health, Dermatology
Chelsea and Westminster Hospital NHS Foundation Trust
Imperial College London
London, United Kingdom

Marta Boffito, MD, PHD, FRCP: consultant/advisor/speaker: AstraZeneca, Atea, Gilead, Merck Sharp and Dohme, Pfizer, Roche, ViiV.

Michelle Cespedes, MD, MS

Professor of Medicine
Division of Infectious Disease
Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Michelle Cespedes, MD, MS: consultant/advisor/speaker: Gilead, ViiV.